Browsing Centre for Biochemical Pharmacology by Subject "Tandem Mass Spectrometry"

Now showing items 1-3 of 3

    • Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. 

      Palmas, F; Clarke, J; Colas, RA; Gomez, EA; Keogh, A; Boylan, M; McEvoy, N; McElvaney, OJ; McElvaney, O; Alalqam, R (Public Library of Science, 2021-08-26)
      Coronavirus disease (COVID)-19, as a result of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has been the direct cause of over 2.2 million deaths worldwide. A timely coordinated host-immune response ...

    • Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis. 

      Dalli, J; Colas, RA; Walker, ME; Serhan, CN (2018)
      Solid-phase extraction coupled with liquid chromatography tandem mass spectrometry provides a robust and sensitive approach for the identification and quantitation of specialized pro-resolving mediators (lipoxins, resolvins, ...

    • Trypanosoma cruzi Produces the Specialized Proresolving Mediators Resolvin D1, Resolvin D5, and Resolvin E2. 

      Colas, RA; Ashton, AW; Mukherjee, S; Dalli, J; Akide-Ndunge, OB; Huang, H; Desruisseaux, MS; Guan, F; Jelicks, LA; Matos Dos Santos, F (2018-04)
      Trypanosoma cruzi is a protozoan parasite that causes Chagas disease (CD). CD is a persistent, lifelong infection affecting many organs, most notably the heart, where it may result in acute myocarditis and chronic ...